Send me more jobs like this

Assistant Manager- Program Management Support

Keywords / Skills : Sound written and verbal communication (English), Basic Knowledge in MS Excel, Email etiquette, Strong inclination to learn new process / tools

3 - 7 years
Posted: 2018-12-14

Job Description
a. Creation of Service Request (SR) for third party outsourced services

b. Creation of Service Entry (SE) for the approved invoices and handover for Bill Forwarding Note (BFN) creation

c. New vendor (service provider) creation in SAP

d. Co-ordinate with SCM and other stake holders for shipping the material with complete set of documentation with end to end tracking

e. Track shipment/service bills/Logistics bills in XL and generate MIS reports

f. Communicate and update the program manager or any relevant stakeholder on the status of shipment On-time

g. Prepare and coordinate signature of Statement of Work (SoW) after the Service Order (SO) is issued



About Company

Biocon is Asia’s premier biopharmaceutical company that is driven by the vision to make a difference to global healthcare through improved access to high quality, life-saving biotherapeutics by making them affordable for patients across the world.

We have evolved from manufacturing pharmaceuticals like statins and immunosuppresants, to discovering, developing and producing biologics in chronic therapies such as diabetes, oncology and immunology for global markets. This has translated into a diversified and differentiated pipeline of fermentation-derived complex generics, biosimilars that include insulins and monoclonal antibodies, and novel biologics.

Biocon is among the few companies globally to have received approvals for its biosimilars from developed countries like the U.S., EU, Australia and Japan. Our credibility as a serious player in the biosimilars sector was first established with the Japanese approval for Insulin Glargine. The credibility was enhanced when Biocon, along with partner Mylan, became the first globally to get biosimilar Trastuzumab and Pegfilgrastim approved in the U.S. in 2017 and 2018, respectively. We were also among the first few to receive Insulin Glargine approval in Europe and Australia for Insulin Glargine, both in partnership with Mylan. We have also established our presence in key emerging markets through safe, effective and high quality biosimilars including recombinant human insulin.

A combination of specialized talent, state-of-the-art research and manufacturing infrastructure and a culture of deep science and regulatory compliance have differentiated us in the marketplace and given us a distinct competitive edge. It has also led to Biocon being recognized as a credible global biopharmaceuticals player.
Similar Jobs
View All Similar Jobs
Walkin for you